Vistagen Therapeutics, Inc. · NASDAQ:VTGN

Great Point Partners LLC's stake in Vistagen Therapeutics, Inc. fell to 4.95% (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 17, 2026

Great Point Partners LLC's stake in Vistagen Therapeutics, Inc. fell to 4.95%, 2,055,834 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).

Stake
4.95%
Shares
2,055,834
Intent
Passive
What changed
Fell below 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Great Point Partners, LLC4.95%2,055,834
Dr. Jeffrey R. Jay, M.D.4.95%2,055,834
Ms. Lillian Nordahl4.95%2,055,834

Source

View original at SEC

Related